SCHEMBL19913331

SCHEMBL19913331

N#Cc1cc(-n2c3ccccc3c3ccc(-c4ccccc4-c4ccccc4)cc32)c(-c2ccncc2)cc1-n1c2ccccc2c2ccc(-c3ccccc3-c3ccccc3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 1/20 0.40
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HIF1A Q16665 1/20 0.35
IMPDH2 P12268 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.34
PRKACA P17612 1/20 0.34
CDK8 P49336 1/20 0.34
CLK2 P49760 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
CDK9 P50750 1/20 0.34
CDK5 Q00535 1/20 0.34
PRKCQ Q04759 1/20 0.34
ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22170385 0.96 SQOR (0.37) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19909482 0.94 IMPDH2 (0.41) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19913123 0.93 TRPA1 (0.41) SQORCYP1A2CYP2C19CYP11B1CYP11B2
SCHEMBL19919823 0.93 SQOR (0.40) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19913326 0.93 SQOR (0.40) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19909463 0.92 IMPDH2 (0.42) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19909158 0.91 SQOR (0.38) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19919613 0.91 TRPA1 (0.43) SQORCYP1A2CYP2C19CYP11B1CYP11B2
SCHEMBL20924032 0.90 PDE10A (0.38) SQORCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL20923721 0.90 TRPA1 (0.39) SQORCYP1A2CYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 SQOR 1580/4885CYP1A2 344/4885CYP2C9 102/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 SQOR 1580/4885CYP1A2 344/4885CYP2C9 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.